A Study Comparing Propranolol and Amantadine for Reducing Tremors in People With Parkinson's Disease

NACompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

July 5, 2024

Primary Completion Date

December 2, 2024

Study Completion Date

December 2, 2024

Conditions

Parkinson Disease (PD)Tremor

Interventions

DRUG

propranolol

40 mg orally twice daily, titrated up to a maximum of 80 mg/day.

DRUG

Amantadine

100 mg orally twice daily, titrated up to a maximum of 200 mg/day.

Trial Locations (1)

Multan Medical and Dental College, Multan

All Listed Sponsors

lead

Multan Medical And Dental College

OTHER

NCT07113015 - A Study Comparing Propranolol and Amantadine for Reducing Tremors in People With Parkinson's Disease | Biotech Hunter | Biotech Hunter